A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markersSarkis Hamalian, Jonathan A. Kelber, Eric Vickers et al.|Oncogene|2021Cited by 30
Abstract 2140: Mesenchymal stromal cells expressing a PEAK1/Cripto axis sustain pro-survival NF-κB signaling in adjacent tumor cells to promote disease progression and therapy resistanceSarkis Hamalian, Jonathan A. Kelber, Robert Güth et al.|Cancer Research|2018Cited by 0